Edition:
India

People: Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

200.25USD
18 Oct 2019
Change (% chg)

$-1.25 (-0.62%)
Prev Close
$201.50
Open
$201.04
Day's High
$202.26
Day's Low
$198.48
Volume
59,735
Avg. Vol
65,912
52-wk High
$217.11
52-wk Low
$132.75

Steer, Randolph 

Dr. Randolph C. Steer M.D. Ph.D. is Independent Director of Bio-Techne Corporation. Dr. Randolph Steer is currently an independent biotechnology consultant and board director. He served as President and Chief Operating Officer of Capstone Therapeutics Corp. from April 2006 to October 2011. Dr. Steer was elected to the Mayo Clinic Board of Trustees in November 2011, and until recently served as a director of publicly-traded Vital Therapies, Inc. From 1989 to 2006 Dr. Steer was a consultant to the pharmaceutical and biotechnology industries, where he advised companies in business development, medical marketing and regulatory and clinical affairs. His prior experience includes service as Associate Director of Medical Affairs at Marion Laboratories and as Medical Director at Ciba Consumer Pharmaceuticals. Dr. Steer received his undergraduate degree in physiology and Ph.D. in pathobiology from the University of Minnesota and his medical degree from the Mayo Medical School. Among other attributes, skills and qualifications, the Board believes Dr. Steer is qualified to serve as a Director of the Company because his medical and scientific backgrounds, his experience in executive leadership and on boards, and his knowledge of the pharmaceutical and biotechnology industries all provide valuable strategic insight.

Basic Compensation

Total Annual Compensation, USD 80,000
Restricted Stock Award, USD 92,412
Long-Term Incentive Plans, USD --
All Other, USD 93,473
Fiscal Year Total, USD 265,885

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Baumgartner

308,385

Charles Kummeth

9,664,870

James Hippel

2,448,890

Brenda Furlow

1,218,200

David Eansor

1,591,280

Robert Gavin

1,374,490
As Of  30 Jun 2018